CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Beneficial effect of bortezomib pre-treatment on cholecystokinin-octapeptide-(CCK-8)-induced experimental pancreatitis
DOI 10.1055/s-2008-1079701
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Szabolcs, G Biczó, Z Rakonczay, L Tiszlavicz, Z Csorba, T Wittmann, T Takács
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe05/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
The proteosome inhibitor bortezomib is used in the treatment of patients with myeloma multiplex. Proteosomes are responsible for the degradation of I-κB, the inhibitory protein of the inflammatory transcription factor nuclear factor kappa B (Nf-κB). The heat shock protein (HSP) inducing effect of bortezomib is also documented. The role of Nf-κB and HSP72 in the development of acute pancreatitis is well known. The Ai…
Zitieren
Zitierempfehlung
A Szabolcs, G Biczó, Z Rakonczay, L Tiszlavicz, Z Csorba, T Wittmann, T Takács (2008) Beneficial effect of bortezomib pre-treatment on cholecystokinin-octapeptide-(CCK-8)-induced experimental pancreatitis. Zeitschrift für Gastroenterologie (05). https://doi.org/10.1055/s-2008-1079701
Mit CareLit weiterarbeiten